Joshua P. Schiff
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Joshua P. Schiff has a total of 168 co-authors. Here are the top co-authors by number of shared publications:
- Lauren E. Henke
University Hospitals Seidman Cancer Center, 11100 Euclid Ave, Cleveland, OH 44106, USA
8 shared publications - Hyun Kim
City of Hope National Medical Center, Los Angeles, CA
6 shared publications Shahed N. Badiyan
Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas
6 shared publications- Alex T. Price
Department of Radiation Oncology University Hospitals Seidman Cancer Center Case Western Reserve University School of Medicine Cleveland Ohio USA
5 shared publications Geoffrey D. Hugo
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA
5 shared publicationsClifford G. Robinson
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA
4 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Elsevier in Medical Dosimetry
A clinical evaluation of spiral 4DCT and intelligent 4DCT sequence scanning
- 23 October 2026
- Published by Elsevier in Medical Dosimetry
Open AccessA clinical evaluation of spiral 4DCT and intelligent 4DCT sequence scanning
- Open Access
- 9 March 2026
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 25, e7
Practical considerations for implementing an adaptive or non-adaptive direct-to-unit radiotherapy programme
Introduction: Direct-to-unit (DTU) radiotherapy is an increasingly popular treatment paradigm in which a traditional computed tomography simulation (CT-sim) is foregone, and a patient’s diagnostic imaging (DI) is used for treatment planning. DTU can be delivered with (ART-DTU) or without online adaptation (non-ART-DTU). Herein, we describe considerations for the implementation of both non-ART and ART DTU. Innovation: DI selection criteria are dependent on the technique in use, as ART DTU image criteria may be less strict due to the capability to adapt to the anatomy of the day. Patient-related selection criteria for DTU include the ability to tolerate increased time on the table as well as the target location. Clinic needs and billing considerations must be addressed prior to formally installing a DTU programme. Discussion: DTU workflows will increase in complexity with the advent of new and intriguing technology. It is also anticipated that DTU will increase in popularity as efficient workflows for oligometastatic patients become more in vogue. Evaluation of this technique in prospective clinical trials is critical. Recommendations: DTU can be beneficial to patients, but great care must be taken when installing these workflows into the clinic. Close coordination between physicians and physicists and careful assessment of clinic demands are essential to success.
- 9 March 2026
- Published by Cambridge University Press (CUP) in Journal of Radiotherapy in Practice
- Vol. 25, e7
Open AccessPractical considerations for implementing an adaptive or non-adaptive direct-to-unit radiotherapy programme
Introduction: Direct-to-unit (DTU) radiotherapy is an increasingly popular treatment paradigm in which a traditional computed tomography simulation (CT-sim) is foregone, and a patient’s diagnostic imaging (DI) is used for treatment planning. DTU can be delivered with (ART-DTU) or without online adaptation (non-ART-DTU). Herein, we describe considerations for the implementation of both non-ART and ART DTU. Innovation: DI selection criteria are dependent on the technique in use, as ART DTU image criteria may be less strict due to the capability to adapt to the anatomy of the day. Patient-related selection criteria for DTU include the ability to tolerate increased time on the table as well as the target location. Clinic needs and billing considerations must be addressed prior to formally installing a DTU programme. Discussion: DTU workflows will increase in complexity with the advent of new and intriguing technology. It is also anticipated that DTU will increase in popularity as efficient workflows for oligometastatic patients become more in vogue. Evaluation of this technique in prospective clinical trials is critical. Recommendations: DTU can be beneficial to patients, but great care must be taken when installing these workflows into the clinic. Close coordination between physicians and physicists and careful assessment of clinic demands are essential to success.
- 21 January 2026
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 125 (4) , 1101-1110
Phase I De-escalated RT in Endometrial Cancer
- 21 January 2026
- Published by Elsevier in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
- Vol. 125 (4) , 1101-1110
Phase I De-escalated RT in Endometrial Cancer
- Open Access
- 25 June 2025
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine Open
- Vol. 2 (3)
Biology-guided Radiotherapy
Background: Advancements in technology allowing the advent of stereotactic body radiation therapy (SBRT) and inclusion of PET imaging into radiation oncology workflows have shaped modern radiation oncology treatment planning and delivery. The X1 (RefleXion Medical) is a novel radiation delivery device that is equipped with PET arcs, which guide the linear accelerator (linac) portion of the machine, allowing for the delivery of biology-guided radiotherapy (BgRT) in which the PET signal is actively used to target external beam radiotherapy during treatment delivery. We provide a review of the X1 machine and BgRT workflow, as well as early cases delivered on the X1 device. Patients and Methods: The X1 device and BgRT workflow are described in detail. Key components of the machine include its two 90-degree PET detector arcs, which collect PET data in real time, enabling the delivery of BgRT. The BgRT workflow is unique from the standard radiation oncology workflow in that radiotracer injections and X1 PET scans are performed as a part of treatment planning, as well as immediately before and during each fraction of BgRT for treatment guidance. Results: We describe 4 of the first BgRT cases including successful treatments of lung (peripheral and central) and bone tumors, as well as unsuccessful treatment of a bone metastasis. Conclusions: BgRT is an emerging treatment paradigm in which PET signals are used in real time to direct external beam radiotherapy. Currently cleared for FDG-guidance for lung and bone tumors, further research is needed to expand the indications and availability of various radiotracers for BgRT delivery.
- 25 June 2025
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine Open
- Vol. 2 (3)
Open AccessBiology-guided Radiotherapy
Background: Advancements in technology allowing the advent of stereotactic body radiation therapy (SBRT) and inclusion of PET imaging into radiation oncology workflows have shaped modern radiation oncology treatment planning and delivery. The X1 (RefleXion Medical) is a novel radiation delivery device that is equipped with PET arcs, which guide the linear accelerator (linac) portion of the machine, allowing for the delivery of biology-guided radiotherapy (BgRT) in which the PET signal is actively used to target external beam radiotherapy during treatment delivery. We provide a review of the X1 machine and BgRT workflow, as well as early cases delivered on the X1 device. Patients and Methods: The X1 device and BgRT workflow are described in detail. Key components of the machine include its two 90-degree PET detector arcs, which collect PET data in real time, enabling the delivery of BgRT. The BgRT workflow is unique from the standard radiation oncology workflow in that radiotracer injections and X1 PET scans are performed as a part of treatment planning, as well as immediately before and during each fraction of BgRT for treatment guidance. Results: We describe 4 of the first BgRT cases including successful treatments of lung (peripheral and central) and bone tumors, as well as unsuccessful treatment of a bone metastasis. Conclusions: BgRT is an emerging treatment paradigm in which PET signals are used in real time to direct external beam radiotherapy. Currently cleared for FDG-guidance for lung and bone tumors, further research is needed to expand the indications and availability of various radiotracers for BgRT delivery.
- 1 December 2024
- Published by Anderson Publishing, Ltd. in Applied Radiation Oncology
- Vol. 13 (4) , 6-16
Workflow Considerations for Implementing a Cone-Beam CT-Guided Adaptive Radiation Therapy Program
Cone-beam CT-guided adaptive radiation therapy (CTgART) is an emerging treatment paradigm that enables the delivery of online adaptive radiation therapy (ART) using CT-based onboard imaging. Our department installed and implemented a CTgART system in 2019 and has since developed workflows for the delivery of CTgART to a wide variety of disease sites. Herein we describe workflow considerations for implementing a CTgART program with a specific focus on the template-based treatment planning methodology that drives online adaptive plan creation on our department’s CTgART platform (Ethos; Varian Medical Systems, Palo Alto, CA). We describe disease-site-specific information for the delivery of CTgART to the thorax, abdomen, prostate, and bladder, and discuss future directions for this technology, which is becoming increasingly accessible and utilized in radiation oncology.
- 1 December 2024
- Published by Anderson Publishing, Ltd. in Applied Radiation Oncology
- Vol. 13 (4) , 6-16
Workflow Considerations for Implementing a Cone-Beam CT-Guided Adaptive Radiation Therapy Program
Cone-beam CT-guided adaptive radiation therapy (CTgART) is an emerging treatment paradigm that enables the delivery of online adaptive radiation therapy (ART) using CT-based onboard imaging. Our department installed and implemented a CTgART system in 2019 and has since developed workflows for the delivery of CTgART to a wide variety of disease sites. Herein we describe workflow considerations for implementing a CTgART program with a specific focus on the template-based treatment planning methodology that drives online adaptive plan creation on our department’s CTgART platform (Ethos; Varian Medical Systems, Palo Alto, CA). We describe disease-site-specific information for the delivery of CTgART to the thorax, abdomen, prostate, and bladder, and discuss future directions for this technology, which is becoming increasingly accessible and utilized in radiation oncology.
- Open Access
- 11 August 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 200, 110473
Dosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally advanced pancreatic adenocarcinoma
- 11 August 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 200, 110473
Open AccessDosimetric predictors of acute and late gastrointestinal toxicities in stereotactic online adaptive magnetic resonance-guided radiotherapy (SMART) for locally advanced pancreatic adenocarcinoma
- Open Access
- 1 March 2024
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 30, 100242
The impact of an Advanced Practice Radiation Therapist contouring for a CBCT-based adaptive radiotherapy program
- 1 March 2024
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 30, 100242
Open AccessThe impact of an Advanced Practice Radiation Therapist contouring for a CBCT-based adaptive radiotherapy program
- Open Access
- 21 July 2023
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 42, 100661
Initial clinical experience building a dual CT- and MR-guided adaptive radiotherapy program
- 21 July 2023
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 42, 100661
Open AccessInitial clinical experience building a dual CT- and MR-guided adaptive radiotherapy program
- Open Access
- 19 April 2023
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 41, 100627
Clinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience
- 19 April 2023
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 41, 100627
Open AccessClinical outcomes of patients with unresectable primary liver cancer treated with MR-guided stereotactic body radiation Therapy: A Six-Year experience
- Open Access
- 29 March 2023
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 8 (6) , 101226
Prospective In Silico Evaluation of Cone-Beam Computed Tomography-Guided StereoTactic Adaptive Radiation Therapy (CT-STAR) for the Ablative Treatment of Ultracentral Thoracic Disease
- 29 March 2023
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 8 (6) , 101226
Open AccessProspective In Silico Evaluation of Cone-Beam Computed Tomography-Guided StereoTactic Adaptive Radiation Therapy (CT-STAR) for the Ablative Treatment of Ultracentral Thoracic Disease